C
CorVista Health
Analytics 4 Life - Pioneering digital health using artificial intelligence to develop a completely new form of medical imaging for coronary artery disease
About CorVista Health
CorVista is a healthcare startup that has developed a revolutionary, non-invasive cardiac diagnostic platform known as the CorVista System. This system is designed to detect and evaluate cardiovascular anomalies, including Coronary Artery Disease (CAD), without the need for radiation or traditional stress testing. The system uses advanced mathematics, physics, and machine learning to provide predictive assessments on cardiovascular disease.
Read full description
The CorVista System serves a broad range of clients, including patients experiencing symptoms such as shortness of breath and irregular heart rate, as well as healthcare providers in various settings, including rural and underserved areas. The system is designed to be user-friendly, requiring no specialist training, and can deliver results within minutes, aiding in rapid diagnosis and treatment.
The business model of CorVista is based on the provision of this diagnostic platform to healthcare providers. The system collects patient signals on a simple digital device and uses powerful machine-learned algorithms to analyze the data. This data is then automatically transferred to the cloud where complex mathematical calculations are performed to generate results on the presence of cardiovascular disease. The results are made available to physicians in a secure web portal shortly after the procedure.
CorVista makes money by charging healthcare providers for the use of their diagnostic platform. The system is designed to be non-additive to healthcare costs, meaning it doesn't add extra expenses to the healthcare system but rather streamlines the diagnostic process, potentially saving costs in the long run.
At a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Toronto, Canada
- Open positions
- None listed
- Dealroom signal
- 24.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Cardiology and cardiovascular, Core AI, Tech for Hospitals and Clinics, Clinical Decision Support, Hard Tech, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning CorVista Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Mar 2021 | $65M | $260M | Ambix Life Science Fund I · MedVenture Partners | ↗ |
| SERIES BOther financing | Sep 2017 | $18M | $73M | Undisclosed | — |
Growth signals
Latest recorded traffic for CorVista Health is 3.8K monthly website visits, down 2.6% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- AIAmbix Life Science Fund I
MedVenture Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about CorVista Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CorVista Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.